Results for "Dasatinib Quercetin"

20 articles

New RAS Inhibitor Daraxonrasib Beats Chemo in Metastatic Pancreatic Cancer
Cancer Research

New RAS Inhibitor Daraxonrasib Beats Chemo in Metastatic Pancreatic Cancer

Phase 3 trial shows daraxonrasib significantly extends survival in previously treated pancreatic cancer patients.

Video
Jul 27, 2026 0
Dual Drug Combo Beats Standard Care in Kidney Cancer After Surgery
Cancer Research

Dual Drug Combo Beats Standard Care in Kidney Cancer After Surgery

Adding belzutifan to pembrolizumab improves disease-free survival in resected clear-cell renal-cell carcinoma, but toxicity rises sharply.

Video
Jul 7, 2026 0
New Drug Daraxonrasib Doubles Pancreatic Cancer Survival in Landmark Trial
Longevity & Aging

New Drug Daraxonrasib Doubles Pancreatic Cancer Survival in Landmark Trial

A KRAS-targeting drug earned a standing ovation at ASCO 2026 by doubling survival in one of cancer's deadliest forms.

Video
Jun 26, 2026 0
Dr. Brad Stanfield Explains Why He Chooses Low-Dose Tirzepatide Daily
Longevity & Aging

Dr. Brad Stanfield Explains Why He Chooses Low-Dose Tirzepatide Daily

A physician breaks down the expanding benefits of GLP-1 medications — from heart and kidney health to joints and cancer — and why tirzepatide wins.

Video
Jun 26, 2026 0
NAD Supplementation and Cancer Risk Debate Explained by Leading Researcher
Supplements

NAD Supplementation and Cancer Risk Debate Explained by Leading Researcher

Expert analysis reveals why NAD's anti-cancer benefits may outweigh potential risks despite ongoing scientific debate.

Video
Mar 28, 2026 0
Teclistamab Beats Standard Therapy in Relapsed Multiple Myeloma Phase 3 Trial
Cancer Research

Teclistamab Beats Standard Therapy in Relapsed Multiple Myeloma Phase 3 Trial

The MajesTEC-9 trial shows teclistamab significantly improves 18-month progression-free survival in relapsed multiple myeloma patients.

Video
Aug 4, 2026 0
New PCSK9 Inhibitor Drug Cuts Heart Disease Risk by 25% in Breakthrough Trial
Longevity & Aging

New PCSK9 Inhibitor Drug Cuts Heart Disease Risk by 25% in Breakthrough Trial

Major cardiovascular trial shows PCSK9 inhibitors prevent first heart attacks and strokes, plus new oral formulation makes treatment more accessible.

Video
Mar 28, 2026 0
New Triple-Agonist Drug Achieves 29% Weight Loss But Raises Safety Concerns
Longevity & Aging

New Triple-Agonist Drug Achieves 29% Weight Loss But Raises Safety Concerns

Retatrutide shows unprecedented weight loss results in phase 3 trials, but higher side effects may limit its advantage over existing medications.

Video
Mar 28, 2026 1
What Years of Statin Use Actually Does to Your Body — and What to Do About It
Heart Health

What Years of Statin Use Actually Does to Your Body — and What to Do About It

Dr. Berg breaks down how statins deplete CoQ10, raise diabetes risk, and why addressing root causes of high cholesterol may matter more.

Video
Sep 6, 2026 0
Statins Beat Every Supplement Tested for LDL Reduction — But the Study Has Flaws
Nutrition & Diet

Statins Beat Every Supplement Tested for LDL Reduction — But the Study Has Flaws

A Cleveland Clinic trial pitted rosuvastatin against six supplements. The drug won — but the supplement choices raise serious questions.

Video
Jun 26, 2026 0
Secukinumab Beats Steroids Alone for Relapsed Polymyalgia Rheumatica
Autoimmune & Arthritis

Secukinumab Beats Steroids Alone for Relapsed Polymyalgia Rheumatica

The REPLENISH phase 3 trial shows secukinumab plus a steroid taper drives higher remission rates in relapsed PMR than steroids alone.

Video
Aug 18, 2026 0
L-Serine Outperforms Popular Antioxidants by Activating Cellular Defense Pathways
Nutrition & Diet

L-Serine Outperforms Popular Antioxidants by Activating Cellular Defense Pathways

Thomas DeLauer explains why L-serine may be more effective than vitamin C, NAC, and turmeric by boosting your body's natural antioxidant systems.

Video
Mar 28, 2026 0
Vitamin D Supplementation Reduces Dementia Risk by 40% in Major Study
Longevity & Aging

Vitamin D Supplementation Reduces Dementia Risk by 40% in Major Study

New research on 12,000+ adults reveals vitamin D's powerful brain protection, even for genetic risk carriers.

Video
Mar 28, 2026 0
Max Lugavere: Could a Common Drugstore Drug Help Prevent Cancer?
Cancer Research

Max Lugavere: Could a Common Drugstore Drug Help Prevent Cancer?

A short-form video by Max Lugavere suggesting a common drugstore drug may have cancer-prevention potential. Specific drug and evidence not available from metadata.

Video
Jul 25, 2026 0
Fenugreek Shows Promise for Diabetes Prevention and Blood Sugar Control
Nutrition & Diet

Fenugreek Shows Promise for Diabetes Prevention and Blood Sugar Control

Research reveals how this ancient spice's unique amino acid helps regulate insulin naturally without dangerous blood sugar crashes.

Video
Mar 28, 2026 0
Setmelanotide Beats Placebo for Hypothalamic Obesity in Landmark TRANSCEND Trial
Metabolic Health

Setmelanotide Beats Placebo for Hypothalamic Obesity in Landmark TRANSCEND Trial

A melanocortin-4 receptor agonist significantly reduced BMI and hunger in patients with acquired hypothalamic obesity over 52 weeks.

Video
Jul 13, 2026 0
New Vitamin D Study Changes Heart Attack Prevention Strategy for High Risk Patients
Longevity & Aging

New Vitamin D Study Changes Heart Attack Prevention Strategy for High Risk Patients

TARGET-D trial shows 52% reduction in repeat heart attacks when vitamin D levels are optimized above 40 ng/mL in cardiac patients.

Video
Mar 29, 2026 0
New FDA-Approved COPD Drug Ensifentrine Shows Promise in Major Clinical Trials
Heart Health

New FDA-Approved COPD Drug Ensifentrine Shows Promise in Major Clinical Trials

First new COPD medication in over a decade targets dual pathways to improve breathing and reduce inflammation.

Video
Mar 29, 2026 7
ADT Plus Apalutamide Boosts Metastasis-Free Survival in High-Risk Prostate Cancer
Cancer Research

ADT Plus Apalutamide Boosts Metastasis-Free Survival in High-Risk Prostate Cancer

Phase 3 PROTEUS trial shows perioperative apalutamide combined with ADT significantly improves pathological response and 5-year metastasis-free survival.

Video
Aug 12, 2026 0
DEET vs Natural Mosquito Repellents: What Science Says About Protection and Safety
Nutrition & Diet

DEET vs Natural Mosquito Repellents: What Science Says About Protection and Safety

Research-backed comparison of DEET, picaridin, and natural alternatives for mosquito protection and disease prevention.

Video
Mar 29, 2026 2
Page 1 of 2Next